四个目标在坟墓轨道病变的发病过程中的作用
Ziqiang Ren1,2, Hailing Zhang1, Haiwen Yu1
1College of Life Sciences, Yantai University, Shandong, China.
Heliyon
|October 9, 2023
概括
格雷夫斯轨道病 (GO) 治疗正在超越目前的治疗方法. 研究正在探索新的标,如介素-23受体 (IL-23R) 和瘦素受体 (LepR),以改善这种复杂的自身免疫性疾病的结果.
科学领域:
- 免疫学和内分泌学.
- 眼科和自身免疫性疾病
背景情况:
- 格雷夫斯轨道病 (GO) 是一种复杂的自身免疫性疾病,影响眼睛,涉及复杂的免疫系统相互作用.
- 目前的治疗方法,包括手术和非特异性/向性药物疗法 (例如,托西利祖马布,利图西马布),在疗效和副作用方面存在局限性.
- 针对IGF-IR的teprotumumab显示出希望,但GO的潜在病理生理学仍然不完全理解.
研究的目的:
- 通过检查免疫细胞和纤维细胞相互作用来探索Graves轨道病变 (GO) 的发病原因.
- 为了识别和突出新的潜在治疗目标GO超出现有的治疗方式.
- 深入了解GO免疫反应反通路,以改善临床管理.
主要方法:
- 审查和讨论目前对GO病原学的理解.
- 探索免疫系统组件和纤维细胞在疾病发展中的作用.
- 基于疾病机制,识别和分析潜在的新型治疗点.
主要成果:
- GO的病理生理学涉及免疫细胞和纤维细胞之间的复杂相互作用,持续存在不确定性.
- 现有的向疗法,如托西利祖马布 (tocilizumab) 和利图西马布 (rituximab),表现出有限的疗效和潜在的副作用.
- 已经确定了四个GO的有希望的潜在治疗点:IL-23R,LepR,轨道纤维细胞激活因子和PAI-1.
结论:
- 对GO病原和免疫信号通路的全面理解对于开发有效的治疗方法至关重要.
- 针对新的途径,包括IL-23R,LepR,轨道纤维细胞激活因子和PAI-1,可能为GO患者提供更好的治疗策略.
- 对这些潜在目标的进一步研究对于推进格雷夫斯轨道病的临床管理至关重要.
相关概念视频
01:25Glaucoma: Overview
604
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
604
01:17Accessory Structures of the Eye
1.6K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
1.6K
01:20Synthesis and Regulation of Thyroid Hormones
4.7K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.7K
01:17Gastritis-II: Pathophysiology
357
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
357
01:26Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
01:27Open Angle Glaucoma: Treatment
472
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
472